TYVASO DPI IS NOW APPROVED

Skip to main content

For the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.

FOR US HEALTHCARE PROFESSIONALS ONLY

Skip to main content

RESOURCE LIBRARY

HCP resources

For your patients

Referral form icon

Referral Form

RX icon

Prescribing Information for TYVASO

RX icon

Prescribing Information for TYVASO DPI

TYVASO DPI HCP Titration Guide

About TYVASO DPI

Efficiency of Inhalational Drug Delivery: Important Considerations

Inhaled Drug Delivery: Direct to Site of Disease

DPI=dry powder inhaler.

Get in contact with a United Therapeutics Representative